About the Company
Trovagene, Inc. is a clinical-stage, precision cancer medicine oncology therapeutics company, which engages in the development of drugs that target cell division (mitosis), for the treatment of various cancers including leukemia, lymphomas, and solid tumors. The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan on August 4, 1999 and is headquartered in San Diego, CA.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TROV News
CRDF Cardiff Oncology, Inc.
The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology ...
Antonius Schuh's Net Worth
Inc., TRANSGENOMIC INC, Trovagene, Inc., and SEQUENOM INC. Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio ...
Liquid biopsies set to transform cancer care
Trovagene is another company working on a urine-based test, which, if they prove reliable, represent an even simpler and potentially cheaper way of diagnosing cancer and other diseases earlier.
Buy Rating Affirmed on Cardiff Oncology as Phase 2 Trial Shows Promise for Accelerated Approval
Begin your TipRanks Premium journey today. Cardiff Oncology (CRDF) Company Description: Trovagene, Inc. is a clinical-stage, precision cancer medicine oncology therapeutics company, which engages in ...
Cardiff Oncology (CRDF) Earnings Dates & Reports
View upcoming earnings forecasts and in-depth analysis of company forecasts.
Pitching a Column to Inc.com
Inc. welcomes column proposals from experts and thought leaders at the top of their industries. Your proposal should include: Why you will make an excellent contributor to Inc.com Topics of ...
Hellish Inc.
Hellish Inc. is a procedural action platformer with rogue-like mechanics focused on precise and fluid movement and player progression. Advertisement Hellish Inc. is a procedural action platformer ...
Personalized Medicine – News and Features
Verastem, Inc., entered an agreement with LabCorp® to validate biomarkers for its lead focal adhesion kinase (FAK) inhibitor VS-6063 in the development of an applicable companion diagnostic. with the ...
About Inc.com | Everything You Need to Know to Grow and Start Your Business
Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that ...
Tracking Trends in Lung Cancer Incidence, Death in the U.S.
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Between low-dose CT lung cancer screening and the wide ...
Loading the latest forecasts...